CCND1 and neoplasm: At the molecular level, this response is linked to decreased expression of cyclin D1 and cyclin D3, inhibition of cyclin-dependent kinases (CDK2, CDK4), and downregulation of the PI3K/AKT pathway, which plays a central role in tumor survival and metastatic progression [25,26,27,28,29].